Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01233791 · ClinicalTrials.gov registry record · NA
Diazepam Vaginal Suppositories for High Tone Pelvic Floor Dysfunction.
A NA study, sponsored by TriHealth.
- Completed
- Registry status
- NA
- Development phase
- 48
- Enrollment target
NCT01233791 is a NA study that has completed, run by TriHealth. The registered enrollment target is 48 participants.
The verdict
NCT01233791, a NA study, has completed, sponsored by TriHealth.
- COMPLETED
- Registry status
- NA
- Development phase
- 48 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether vaginal diazepam suppositories are an effective treatment of high tone pelvic floor dysfunction.
Interventions
- DRUG Vaginal Diazepam Suppository
- DRUG Placebo Suppository
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2010-11 |
| Est. Completion | 2011-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01233791
The ClinicalTrials.gov registry entry for NCT01233791 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is TriHealth, which has 81 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vaginal Diazepam Suppository is the first listed.
NCT01233791 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01233791 about?
NCT01233791 is a clinical study titled "Diazepam Vaginal Suppositories for High Tone Pelvic Floor Dysfunction.". The purpose of this study is to determine whether vaginal diazepam suppositories are an effective treatment of high tone pelvic floor dysfunction.
What is the current status of trial NCT01233791?
This trial is currently completed. It is a NA study. The enrollment target is 48 participants. The study started on 2010-11. Estimated completion is 2011-12.
What interventions are being tested in trial NCT01233791?
The interventions under investigation include: Vaginal Diazepam Suppository (DRUG), Placebo Suppository (DRUG).
Who is sponsoring clinical trial NCT01233791?
This trial is sponsored by TriHealth, which has 81 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.